Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
depression
Pharma
Intra-Cellular moves closer to Caplyta depression expansion
With two positive data sets in hand, Intra-Cellular is waiting for a third readout by June to file for Caplyta in major depressive disorder.
Angus Liu
Apr 16, 2024 2:27pm
Bausch starts first TV campaign for seasonal depression drug
Oct 27, 2023 9:20am
AbbVie gives Vraylar ad campaign 'a lift' with new focus
May 9, 2023 9:40am
Intra-Cellular's Caplyta posts sweeping win in depression trial
Mar 29, 2023 11:30am
Sublingual psychedelic startup nets $60M for depression trials
Nov 8, 2022 7:30am
NICE's rebuff of J&J depression nasal spray under scrutiny
Sep 8, 2022 10:15am
